DOK1
Basic information
Region (hg38): 2:74549026-74557551
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DOK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 69 | 54 | 126 | |||
Total | 1 | 0 | 91 | 54 | 2 |
Variants in DOK1
This is a list of pathogenic ClinVar variants found in the DOK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-74549350-G-T | Likely benign (Nov 04, 2023) | |||
2-74549370-T-A | Uncertain significance (Jun 10, 2022) | |||
2-74549374-G-A | Likely benign (Nov 14, 2021) | |||
2-74549377-G-A | LOXL3-related disorder | Likely benign (Jun 09, 2023) | ||
2-74549381-G-A | Uncertain significance (Jul 18, 2022) | |||
2-74549384-T-C | Uncertain significance (Aug 15, 2022) | |||
2-74549391-T-C | not specified | Uncertain significance (Oct 20, 2023) | ||
2-74549403-G-A | LOXL3-related disorder | Uncertain significance (Nov 29, 2023) | ||
2-74549427-C-T | Uncertain significance (Dec 29, 2021) | |||
2-74549464-TTGCGAC-T | Uncertain significance (Nov 03, 2022) | |||
2-74549466-GC-G | Myopia 28, autosomal recessive | Pathogenic (Mar 07, 2022) | ||
2-74549467-C-A | Likely benign (May 17, 2023) | |||
2-74549467-C-G | Likely benign (Oct 07, 2022) | |||
2-74549468-G-T | Uncertain significance (Jul 19, 2022) | |||
2-74549473-G-A | Uncertain significance (Aug 23, 2021) | |||
2-74549475-C-T | Uncertain significance (Mar 10, 2022) | |||
2-74549482-A-G | LOXL3-related disorder | Likely benign (Dec 20, 2023) | ||
2-74549498-A-G | Uncertain significance (Nov 26, 2021) | |||
2-74549500-C-A | Likely benign (Aug 21, 2022) | |||
2-74549500-C-T | Likely benign (Sep 03, 2022) | |||
2-74549502-C-T | Uncertain significance (Sep 07, 2021) | |||
2-74549506-C-T | Likely benign (Nov 10, 2023) | |||
2-74549512-G-A | Likely benign (Mar 14, 2022) | |||
2-74549513-G-A | Uncertain significance (May 22, 2022) | |||
2-74549514-G-T | not specified | Uncertain significance (Aug 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DOK1 | protein_coding | protein_coding | ENST00000233668 | 5 | 8529 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0290 | 0.969 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0926 | 278 | 282 | 0.984 | 0.0000161 | 3073 |
Missense in Polyphen | 71 | 78.692 | 0.90225 | 866 | ||
Synonymous | -0.0126 | 122 | 122 | 1.00 | 0.00000683 | 1039 |
Loss of Function | 2.71 | 6 | 18.6 | 0.322 | 8.17e-7 | 206 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000279 | 0.000275 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000466 | 0.0000462 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK1 appears to be a negative regulator of the insulin signaling pathway. Modulates integrin activation by competing with talin for the same binding site on ITGB3. {ECO:0000269|PubMed:18156175}.;
- Pathway
- Measles - Homo sapiens (human);Kit receptor signaling pathway;VEGFA-VEGFR2 Signaling Pathway;Developmental Biology;Signaling by PTK6;Signal Transduction;TCR;Ghrelin;KitReceptor;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;BCR;IL1;EGFR1;BCR signaling pathway;Signaling by Non-Receptor Tyrosine Kinases;Signaling events regulated by Ret tyrosine kinase;IL3;RET signaling;Axon guidance;TNFalpha;Insulin Pathway;Fc-epsilon receptor I signaling in mast cells;Signaling events mediated by Stem cell factor receptor (c-Kit);PDGFR-beta signaling pathway;Signaling events mediated by PTP1B
(Consensus)
Recessive Scores
- pRec
- 0.224
Intolerance Scores
- loftool
- 0.529
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.12
Haploinsufficiency Scores
- pHI
- 0.436
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.600
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dok1
- Phenotype
- respiratory system phenotype; neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- signal transduction;cell surface receptor signaling pathway;transmembrane receptor protein tyrosine kinase signaling pathway;Ras protein signal transduction;axon guidance;macrophage colony-stimulating factor signaling pathway;positive regulation of epidermal growth factor receptor signaling pathway
- Cellular component
- nucleus;cytosol;perinuclear region of cytoplasm
- Molecular function
- protein binding